MAPLIGHT THERAPEUTICS INC (MPLT) Stock News

USA - Nasdaq - NASDAQ:MPLT - US56565P1030 - Common Stock

18.49 USD

+0.15 (+0.82%)

Last: 12/5/2025, 8:00:00 PM

18.49 USD

0 (0%)

After Hours: 12/5/2025, 8:00:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

MPLT Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: MapLight Therapeutics, Inc.

MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress

2 days ago - By: MapLight Therapeutics, Inc.

MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress

a month ago - By: MapLight Therapeutics, Inc.

MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

a month ago - By: MapLight Therapeutics, Inc.

MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

a month ago - By: Bloomberg - Mentions: GS

Biotech MapLight Jumps 23% in First US IPO Using Shutdown Fix

a month ago - By: Bloomberg

Sergey Brin Nonprofit Gets a $242 Million Lift From MapLight IPO

a month ago - By: Bloomberg - Mentions: GS

Novo-Backed MapLight Raises $258.9 Million in US IPO, Placement

a month ago - By: MapLight Therapeutics, Inc.

MapLight Therapeutics Announces Pricing of Initial Public Offering

a month ago - By: MapLight Therapeutics, Inc.

MapLight Therapeutics Announces Pricing of Initial Public Offering

2 months ago - By: Bloomberg

MapLight Taps Workaround for IPO Despite Government Shutdown

2 months ago - By: Bloomberg - Mentions: GS

Novo-Backed MapLight Seeks $251 Million in US IPO, Placement